Hiroshi Kubo
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 24, 2019
Improving the viability of tissue-resident stem cells using an organ-preservation solution.Takaya Suzuki, Chiharu Ota, Naoya Fujino
|Jun 16, 2018
Guselkumab, an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study.Mamitaro Ohtsuki, Hiroshi Kubo, Hitomi Morishima
|Mar 24, 2018
Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.Shigetoshi Sano, Hiroshi Kubo, Hitomi Morishima
|Dec 10, 2017
Safety and efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: a randomized, placebo-controlled, ascending-dose study.O Nemoto, K Hirose, S Shibata
|Oct 08, 2017
Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach.Rosarin Sruamsiri, Sameh Ferchichi, Aurélien Jamotte
Pageof 1
